Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP

This article was originally published in The Tan Sheet

Executive Summary

Phase One of dietary supplements quality assurance program begins as trustees approve new testing and certification program Jan. 5-6. Announced in September, the program will grant an as-yet undetermined new certification mark to supplements demonstrating adherence to USP's quality standards (1"The Tan Sheet" Sept. 11, 2000, pp. 6-7). USP is gathering industry support for the program; timing for a full launch has not been set

You may also be interested in...



USP Supplement Certification Program Advisory Group Forming

A USP Industry Advisory Group of representatives from the pharmacopeia, FDA and industry will meet in March to begin finalizing the design of USP's dietary supplement quality certification program.

USP Supplement Certification Program Advisory Group Forming

A USP Industry Advisory Group of representatives from the pharmacopeia, FDA and industry will meet in March to begin finalizing the design of USP's dietary supplement quality certification program.

USP Supplement Certification Program Advisory Group Forming

A USP Industry Advisory Group of representatives from the pharmacopeia, FDA and industry will meet in March to begin finalizing the design of USP's dietary supplement quality certification program.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel